We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$571M
AUM Growth
+$64.7M
(+13%)
Cap. Flow
+$77M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$35.4M |
| 2 |
Stellantis
STLA
|
+$22.2M |
| 3 |
PepsiCo
PEP
|
+$18M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$6.64M |
| 5 |
Kohl's
KSS
|
+$5.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$21.5M |
| 2 |
iShares MSCI Indonesia ETF
EIDO
|
+$11.1M |
| 3 |
Eaton
ETN
|
+$4.76M |
| 4 |
Delta Air Lines
DAL
|
+$4.4M |
| 5 |
Western Union
WU
|
+$4.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.66% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Consumer Staples | 8.41% |
| 4 | Energy | 8.01% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares TIPS Bond ETF
TIP
$14.5B
| $369K | 0.06% |
3,196
+277
| +9% | +$31.5K |
|
202
Nike
NKE
$64.1B
| $359K | 0.06% |
4,276
+1,119
| +35% | +$94.2K |
|
203
iShares Silver Trust
SLV
$27.7B
| $357K | 0.06% |
+24,900
| New | +$348K |
|
204
S&P Global
SPGI
$124B
| $356K | 0.06% |
+1,564
| New | +$342K |
|
205
Carnival Corporation Ltd
CCL
$38.1B
| $351K | 0.06% |
7,538
-58,492
| -89% | -$3.06M |
|
206
Biogen
BIIB
$30.9B
| $350K | 0.06% |
1,499
-998
| -40% | -$230K |
|
207
Alcoa
AA
$11.3B
| $328K | 0.06% |
+14,018
| New | +$349K |
|
208
Healthpeak Properties
DOC
$15.5B
| $326K | 0.06% |
10,181
-435
| -4% | -$13.5K |
|
209
NXP Semiconductors
NXPI
$60.8B
| $322K | 0.06% |
3,242
| – | – |
|
|
ARNA
210
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $315K | 0.06% |
+5,379
| New | +$278K |
|
|
211
Western Union
WU
$2.53B
| $315K | 0.06% |
15,839
-212,185
| -93% | -$4.14M |
|
212
Darden Restaurants
DRI
$24.3B
| $310K | 0.05% |
2,551
-12,717
| -83% | -$1.51M |
|
213
Tapestry
TPR
$30.3B
| $309K | 0.05% |
9,731
+1,099
| +13% | +$34.3K |
|
214
Coca-Cola Europacific Partners
CCEP
$49.1B
| $308K | 0.05% |
5,462
+1,055
| +24% | +$57.6K |
|
215
Sarepta Therapeutics
SRPT
$1.64B
| $307K | 0.05% |
2,023
| – | – |
|
216
Mattel
MAT
$4.47B
| $307K | 0.05% |
27,400
+13,389
| +96% | +$157K |
|
217
Blackrock
BLK
$167B
| $304K | 0.05% |
649
+34
| +6% | +$15.4K |
|
218
Pan American Silver
PAAS
$17.9B
| $304K | 0.05% |
23,528
+2,081
| +10% | +$25.1K |
|
219
Union Pacific
UNP
$174B
| $303K | 0.05% |
1,795
-799
| -31% | -$137K |
|
|
ICPT
220
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $301K | 0.05% |
3,787
+3,781
| +63,017% | +$338K |
|
221
SSR Mining
SSRM
$5.19B
| $297K | 0.05% |
21,723
-77,526
| -78% | -$924K |
|
222
iShares MSCI Poland ETF
EPOL
$680M
| $293K | 0.05% |
12,324
+463
| +4% | +$10.6K |
|
|
GWPH
223
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $290K | 0.05% |
1,683
+1,515
| +902% | +$262K |
|
224
Marathon Petroleum
MPC
$90.1B
| $289K | 0.05% |
5,177
-59,745
| -92% | -$3.27M |
|
225
Starbucks
SBUX
$119B
| $281K | 0.05% |
3,353
-16,380
| -83% | -$1.28M |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2019 Portfolio in Review
As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.
- Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
- Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
- Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
- Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
- Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
- Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
- Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.
Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.